Episode 160: Global Covid-19 failures, a sluggish CDC, and a boisterous STAT Health Tech Summit
Can we prevent the next Covid-19? Has the CDC become too cautious? And how many sensors should be worn to bed? First, our colleague Helen Branswell joins us to discuss where the world went wrong with ...
13 Mai 202129min
Episode 159: Thomas Bollyky on patent waivers, plus vaccine riches, & a gene therapy for aging
First, Moderna and Pfizer are poised to make billions of dollars from their Covid-19 vaccines this year, and we discuss what that massive infusion of cash portends for both companies. Next, Thomas Bol...
6 Mai 202133min
Episode 158: Angela Rasmussen on Russia's vaccine controversy, plus Biden's drug pricing punt
First, STAT Washington correspondent Rachel Cohrs joins us to explain why President Biden's endorsement for drug pricing reform rang hollow to many advocates. Next, virologist Angela Rasmussen calls i...
29 Apr 202128min
Episode 157: Mercedes Carnethon on outdoor masking, FDA in limbo, & gene therapy's uncertain upside
First, Northwestern University epidemiologist Mercedes Carnethon joins us to weigh on the nation's latest Covid-19 debate: Is it OK to go maskless outdoors? Then, STAT Washington correspondent Nichola...
22 Apr 202133min
Episode 156: J&J's vaccine pause, talking about remote risks, & why no new drugs for Covid-19
How do you describe a one-in-a-million risk? What's heparin-induced thrombocytopenia? And why's it so hard to find drugs for Covid-19? We cover all that and more this week on “The Readout LOUD,” STAT...
15 Apr 202130min
Episode 155: AstraZeneca's vaccine woes, compassionate use, & giving out Covid vaccines
What's next for AstraZeneca? Are there any right answers when it comes to compassionate use? And how does it feel to give someone a Covid-19 vaccine? We cover all that and more this week on “The Read...
8 Apr 202130min
Episode 154: Eleanor Fox on Illumina’s FTC headache, plus Talkspace’s experiment
First, STAT’s Mario Aguilar joins us to discuss a fascinating experiment in Nevada, where one city is giving its residents free access to a therapy app — and getting a mixed reception. Then, New York ...
1 Apr 202133min
Episode 153: AstraZeneca and the very good, then quite bad, then deeply confusing week
We're devoting this week's episode to the week of whiplash news about AstraZeneca's Covid-19 vaccine, subject of a baffling international incident with consequences still unfolding. First, we explain ...
25 Mar 202127min
